EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Changes in prenatal cannabis‐related diagnosed disorders after the Cannabis Act and the COVID‐19 pandemic in Quebec, Canada

José Ignacio Nazif-Munoz iD, Pablo Martínez, Christophe Huỳnh, Victoria Massamba, Isaora Zefania, Louis Rochette, Helen-Maria Vasiliadis

Addiction · 2024

DOI: 10.1111/add.16564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction, 2024. Verfasst von José Ignacio Nazif-Munoz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de médecine et des sciences de la santé, Université de Sherbrooke-Campus Longueuil, Longueuil, Quebec, Canada. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds de Recherche du Québec-Société et Culture, Fons de Recherche du Québec sur la Nature et les Technologies (FRQNT-PBEEE), Institut universitaire sur les dépendances.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Public health concerns regarding pregnant women’s health after the enactment of the Cannabis Act in Canada (CAC) (a law that allowed non‐medical cannabis use), and the potential impact of the COVID‐19 pandemic, call for a contemporary assessment of these two events. Our study measured associations between the CAC, the COVID‐19 pandemic and the monthly prevalence rates of cannabis‐, all drug‐ and alcohol‐related diagnosed disorders among pregnant women in the province of Quebec. Design, setting and participants This was a quasi‐experimental design applying an interrupted time‐series methodology in the province of Quebec, Canada. The participants were pregnant women aged 15–49 years, between January 2010 and July 2022.

Measurements

Administrative health data from the Québec Integrated Chronic Disease Surveillance System were used to classify pregnant women according to cannabis‐, all drug (excluding cannabis)‐ and alcohol‐related disorders. The CAC (October 2018) and the COVID‐19 pandemic (April 2020) were evaluated as (1) slope changes and (2) level changes. Cannabis‐, all drug (excluding cannabis)‐ and alcohol‐related disorders were measured by total monthly age‐standardized monthly prevalence rate of each disorder for pregnant women aged 15–49 years.

Findings

Before the CAC, the prevalence rate of cannabis‐related diagnosed disorders significantly increased each month by 0.5% [95% confidence interval (CI) = 0.3–0.6] in the pregnant population. After the CAC, there were significant increases of 24% (95% CI = 1–53) of cannabis‐related diagnosed disorders. No significant changes were observed for all drug (excluding cannabis)‐ and alcohol‐related diagnosed disorders associated with the CAC. A non‐significant decrease of 20% (95% CI = −38 to 3) was observed during the COVID‐19 pandemic in alcohol‐related disorders.

Conclusions

The monthly incidence rates of diagnosed cannabis‐related disorders in pregnant women in Quebec increased significantly following the enactment of the Cannabis Act in Canada. Diagnoses of all drug (excluding cannabis)‐ and alcohol‐related disorders remained relatively stable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansFemalePregnancyQuebecAdultAdolescentYoung AdultMiddle AgedPrevalenceMarijuana AbusePregnancy ComplicationsInterrupted Time Series AnalysisPandemicsLegislation, Drug

Stichwörter der Autor:innen

COVID‐19CannabisCannabis ActQuebecprenatal cannabis use disordertime‐series

Autor:innen und Institutionen

  • Faculté de médecine et des sciences de la santé, Université de Sherbrooke-Campus Longueuil, Longueuil, Quebec, Canada.
  • Centre de recherche Charles-Le Moyne, Longueuil, Quebec, Canada.
  • Douglas Research Centre, McGill University, Verdun, Quebec, Canada.
  • Institut national de santé publique du Québec, Quebec, Canada.
  • Institut universitaire sur les dépendances, Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec, Canada.
  • Département de psychiatrie et d'addictologie, Faculté de médecine, Université de Montréal, Montreal, Quebec, Canada.

ORCID-Profile: José Ignacio Nazif-Munoz

Förderung

  • Fonds de Recherche du Québec-Société et Culture
  • Fons de Recherche du Québec sur la Nature et les Technologies (FRQNT-PBEEE)
  • Institut universitaire sur les dépendances

Zitieren

APA

Nazif-Munoz, J. I., Martínez, P., Huỳnh, C., Massamba, V., Zefania, I., Rochette, L., & Vasiliadis, H. M. (2024). Changes in prenatal cannabis‐related diagnosed disorders after the Cannabis Act and the COVID‐19 pandemic in Quebec, Canada. Addiction. https://doi.org/10.1111/add.16564

Vancouver

Nazif-Munoz JI, Martínez P, Huỳnh C, Massamba V, Zefania I, Rochette L, et al. Changes in prenatal cannabis‐related diagnosed disorders after the Cannabis Act and the COVID‐19 pandemic in Quebec, Canada. Addiction. 2024. doi:10.1111/add.16564

BibTeX
@article{NazifMunoz2024,
  author = {Nazif-Munoz, José Ignacio and Martínez, Pablo and Huỳnh, Christophe and Massamba, Victoria and Zefania, Isaora and Rochette, Louis and Vasiliadis, Helen-Maria},
  title = {Changes in prenatal cannabis‐related diagnosed disorders after the Cannabis Act and the COVID‐19 pandemic in Quebec, Canada},
  journal = {Addiction},
  year = {2024},
  doi = {10.1111/add.16564}
}
Kostenlos starten →